Frontlight ResearchEarly access
Trial site
Hassman Research Institute
- 3running trials
- 11closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Obesity4 trials
- Depression3 trials
- Schizophrenia3 trials
- Bipolar disorder2 trials
- Type 2 diabetes2 trials
- Lyme disease1 trial
- Phase
- Phase 36 trials
- Phase 25 trials
- Phase 12 trials
- Phase 2/31 trial
- Status
- Completed10 trials
- Active, not recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Pfizer5 trials
- Biohaven Therapeutics Ltd.2 trials
- Boehringer Ingelheim2 trials
- Definium Therapeutics US, Inc.1 trial
- Denovo Biopharma LLC1 trial
- and 3 more
Running trials
Active, not recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Active, not recruiting
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
Closed trials
Completed
Completed
Terminated
Completed
Completed
Completed
Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005
Completed
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
Completed
Completed
Completed
Completed
A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression
Site data: ClinicalTrials.govUpdated 15 Nov 2026